SCHEMBL29823386

SCHEMBL29823386

COc1ccccc1OC(=O)C=Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.60
▸ ESR1 P03372 1/20 0.60
▸ ESR2 Q92731 1/20 0.60
▸ KMT2A Q03164 7/20 0.58
▸ MEN1 O00255 4/20 0.58
▸ POLB P06746 1/20 0.58
▸ RECQL P46063 1/20 0.58
▸ TNFRSF1A P19438 2/20 0.57
▸ MMP1 P03956 2/20 0.57
▸ EGFR P00533 1/20 0.57
▸ MMP2 P08253 1/20 0.57
▸ MMP9 P14780 1/20 0.57
▸ LMNA P02545 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ GAA P10253 1/20 0.53
▸ MAPT P10636 2/20 0.51
▸ NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9065919 1.00 HTR1A (0.60) HTR1AESR1ESR2KMT2AMEN1
SCHEMBL9065922 1.00 HTR1A (0.60) HTR1AESR1ESR2KMT2AMEN1
SCHEMBL17301255 0.86 HTR1A (0.60) HTR1AKMT2AMEN1TNFRSF1AMMP1
SCHEMBL9284213 0.86 MAPT (0.58) HTR1AKMT2APOLBLMNAHTT
SCHEMBL29823458 0.84 NFE2L2 (0.57) HTR1AESR1ESR2KMT2AMEN1
SCHEMBL7855954 0.84 KMT2A (0.61) HTR1AKMT2AMEN1TNFRSF1AMAPT
SCHEMBL29823740 0.84 KMT2A (0.61) HTR1AKMT2AMEN1TNFRSF1AMAPT
SCHEMBL7855955 0.84 KMT2A (0.61) HTR1AKMT2AMEN1TNFRSF1AMAPT
SCHEMBL7323689 0.83 TNFRSF1A (0.64) HTR1AKMT2AMEN1TNFRSF1AMMP1
SCHEMBL7323696 0.83 TNFRSF1A (0.64) HTR1AKMT2AMEN1TNFRSF1AMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220234987-A1 STYRYL CARBOXYLATE DERIVATIVES Renovel Innovations, Inc. 2022-07-28 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220234987-A1 STYRYL CARBOXYLATE DERIVATIVES ACACB, ACACA, FABP7 HTR1A 2749/4885ESR1 3111/4885ESR2 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback